Research ArticleCLINICAL INVESTIGATIONS
Standardized Uptake Values of 68Ga-DOTANOC PET: A Promising Prognostic Tool in Neuroendocrine Tumors
Davide Campana, Valentina Ambrosini, Raffaele Pezzilli, Stefano Fanti, Antonio Maria Morselli Labate, Donatella Santini, Claudio Ceccarelli, Francesca Nori, Roberto Franchi, Roberto Corinaldesi and Paola Tomassetti
Journal of Nuclear Medicine March 2010, 51 (3) 353-359; DOI: https://doi.org/10.2967/jnumed.109.066662
Davide Campana
Valentina Ambrosini
Raffaele Pezzilli
Stefano Fanti
Antonio Maria Morselli Labate
Donatella Santini
Claudio Ceccarelli
Francesca Nori
Roberto Franchi
Roberto Corinaldesi
In this issue
Journal of Nuclear Medicine
Vol. 51, Issue 3
March 2010
Standardized Uptake Values of 68Ga-DOTANOC PET: A Promising Prognostic Tool in Neuroendocrine Tumors
Davide Campana, Valentina Ambrosini, Raffaele Pezzilli, Stefano Fanti, Antonio Maria Morselli Labate, Donatella Santini, Claudio Ceccarelli, Francesca Nori, Roberto Franchi, Roberto Corinaldesi, Paola Tomassetti
Journal of Nuclear Medicine Mar 2010, 51 (3) 353-359; DOI: 10.2967/jnumed.109.066662
Standardized Uptake Values of 68Ga-DOTANOC PET: A Promising Prognostic Tool in Neuroendocrine Tumors
Davide Campana, Valentina Ambrosini, Raffaele Pezzilli, Stefano Fanti, Antonio Maria Morselli Labate, Donatella Santini, Claudio Ceccarelli, Francesca Nori, Roberto Franchi, Roberto Corinaldesi, Paola Tomassetti
Journal of Nuclear Medicine Mar 2010, 51 (3) 353-359; DOI: 10.2967/jnumed.109.066662
Jump to section
Related Articles
Cited By...
- [18F]FDG PET/CT-Avid Discordant Volume as a Biomarker in Patients with Gastroenteropancreatic Neuroendocrine Neoplasms: A Multicenter Study
- High Tumor Uptake on 18F-FDOPA PET/CT Indicates Poor Prognosis in Patients with Metastatic Midgut Neuroendocrine Tumors: A Study from the Groupe detude des Tumeurs Endocrines and ENDOCAN-RENATEN Network
- 68Ga-DOTATATE PET in Restaging and Response to Therapy in Neuroblastoma: A Case Series and a Mini Review
- 68Ga-DOTATATE PET in Restaging and Response to Therapy in Neuroblastoma: A Case Series and a Mini Review
- Prognostic Value of Whole-Body PET Volumetric Parameters Extracted from 68Ga-DOTATOC PET/CT in Well-Differentiated Neuroendocrine Tumors
- Semiautomatic Tumor Delineation for Evaluation of 64Cu-DOTATATE PET/CT in Patients with Neuroendocrine Neoplasms: Prognostication Based on Lowest Lesion Uptake and Total Tumor Volume
- Somatostatin Receptor Imaging and Theranostics: Current Practice and Future Prospects
- Quantitative 68Ga-DOTATATE PET/CT Parameters for the Prediction of Therapy Response in Patients with Progressive Metastatic Neuroendocrine Tumors Treated with 177Lu-DOTATATE
- 64Cu-DOTATATE PET/CT and Prediction of Overall and Progression-Free Survival in Patients with Neuroendocrine Neoplasms
- Current Concepts in 68Ga-DOTATATE Imaging of Neuroendocrine Neoplasms: Interpretation, Biodistribution, Dosimetry, and Molecular Strategies
- Comparison of the Impact of 68Ga-DOTATATE and 18F-FDG PET/CT on Clinical Management in Patients with Neuroendocrine Tumors
- The Impact of 68Ga-DOTATATE PET/CT Imaging on Management of Patients with Neuroendocrine Tumors: Experience from a National Referral Center in the United Kingdom
- Prognostic Value of 68Ga-DOTANOC PET/CT SUVmax in Patients with Neuroendocrine Tumors of the Pancreas
- 64Cu-DOTATATE PET for Neuroendocrine Tumors: A Prospective Head-to-Head Comparison with 111In-DTPA-Octreotide in 112 Patients
- Quantitative and Qualitative Intrapatient Comparison of 68Ga-DOTATOC and 68Ga-DOTATATE: Net Uptake Rate for Accurate Quantification
- Unexpected Sensitivity of sst2 Antagonists to N-Terminal Radiometal Modifications
- Radiopeptide Imaging and Therapy in Europe
- Incidence of Increased 68Ga-DOTANOC Uptake in the Pancreatic Head in a Large Series of Extrapancreatic NET Patients Studied with Sequential PET/CT
- Volume-of-Interest Assessment of Oncologic Response Using 18F-FDG PET/CT: A Phantom Study